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Abstract
Background: This study investigates the effect of gantry speed on 4DCBCT image quality and dose for the Varian
On-Board Imager®.
Methods: A thoracic 4DCBCT protocol was designed using a 125 kVp spectrum. Image quality parameters were
evaluated for 4DCBCT acquisition using Catphan® phantom with real-time position management™ system for
gantry speeds varying between 1.0 to 6.0°/s. Superior-inferior motion of the phantom was executed using a
sinusoidal waveform with five second period. Scans were retrospectively sorted into 4 phases (CBCT-4 ph) and 10
phases (CBCT-10 ph); average 4DCBCT (CBCT-ave), using all image data from the 4DCBCT acquisitions was also
evaluated. The 4DCBCT images were evaluated using the following image quality metrics: spatial resolution,
contrast-to-noise ratio (CNR), and uniformity index (UI). Additionally, Hounsfield unit (HU) sensitivity compared to a
baseline CBCT and percent differences and RMS errors (RMSE) of excursion were also determined. Imaging dose
was evaluated using an IBA CC13 ion chamber placed within CIRS Thorax phantom using the same sinusoidal
motion and image acquisition settings as mentioned above.
Results: Spatial resolution decreased linearly from 5.93 to 3.82 lp/cm as gantry speed increased from 1.0 to 6.0°/s.
CNR decreased linearly from 4.80 to 1.82 with gantry speed increasing from 1.0 to 6.0°/s, respectively. No
noteworthy variations in UI, HU sensitivity, or excursion metrics were observed with changes in gantry speed. Ion
chamber dose rates measured ranged from 2.30 (lung) to 5.18 (bone) E-3 cGy/mAs.
Conclusions: A quantitative analysis of the Varian OBI’s 4DCBCT capabilities was explored. Changing gantry speed
changes the number of projections used for reconstruction, affecting both image quality and imaging dose if x-ray
tube current is held constant. From the results of this study, a gantry speed between 2 and 3°/s was optimal when
considering image quality, dose, and reconstruction time. The future of 4DCBCT clinical utility relies on further
investigation of image acquisition and reconstruction optimization.
Keywords: Cone-beam CT, Image guidance, Dosimetry, Motion management
* Correspondence: nwen1@hfhs.org
3Department of Radiation Oncology, Henry Ford Health System, Detroit, MI
48202, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Santoso et al. Radiation Oncology  (2016) 11:98 
DOI 10.1186/s13014-016-0677-8
Background
Stereotactic body radiotherapy (SBRT) has become a
form of treating inoperable non-small cell lung cancer
(NSCLC) in its early stages [1]. Work conducted by
Onishi et al. showed that patients staged with T1 and T2
NSCLC treated with SBRT had cumulative local control
rates better than 70 % at 5 years; this is in contrast to
local control rates of 50 % with a 5-year survival of ap-
proximately 15–30 % for patients treated with conven-
tionally fractionated radiotherapy [1]. Five-year relative
survival rates for lung cancers remains somewhat low at
18 %, attributed to more than one-half of diagnoses
made at a distant stage [2].
Though initial clinical results of SBRT for lung cancer
are promising, there remain technical complexities that
must be addressed. In particular, localization error
associated with the treatment of moving targets in lung
SBRT must be minimized [3]. The ability of four-
dimensional CT (4DCT) to map motion and tissue
deformation during respiration, while reducing arti-
facts, allows for accurate targeting of tumors in the
thorax [4, 5]. Strategies to improve target coverage,
such as breath hold treatments, gated delivery, and
mid-position treatments can also be utilized as part
of an approach for respiratory motion management
[4, 6, 7]. Margin reduction is also possible for SBRT,
having subsequent implications for reducing mean
lung dose [8].
Interventional imaging techniques such as cone-
beam CT (CBCT) have become clinical standards in
image-guided radiotherapy for soft tissue-based target
localization and positioning [9]. Linear accelerators
can be mounted with a kV source and flat panel de-
tector, allowing for volumetric image acquisition.
These volumetric images allow for accurate soft tissue
localization and retrospective dose calculation [10].
However, large magnitudes of intra-scan motion in
the reconstructed image can lead to clinically dosi-
metric discrepancies due to poor image quality.
Tumor motion at the treatment position can be assessed
using 4DCBCT [11]. Conventional free-breathing CBCT
tends to underestimate the tumor extent (i.e., the internal
target volume) by as much as 24.2 to 40.1 % depending on
tumor size and interfraction variability [3, 12, 13]. To
allow for binning of projection images, a surrogate re-
spiratory signal is used to determine amplitude, phase, or
temporal information; various methods have been utilized
for the respiratory cycle surrogate, including tracking the
motion of the diaphragm, mapping changes of the skin
surface, thoracic transducer belts, or infrared reflective
markers [14]. The 4D reconstruction involves a retro-
spective correlation of the timing of projection images to
the breathing cycle surrogate parameter of interest (i.e.,
phase or amplitude of respiratory cycle) [4, 15].
The clinical utility of 4DCBCT is dependent on both
image quality and imaging dose. Dosimetric studies have
been conducted for patient skin dose using thermolumin-
escent dosimeters as well as Gafchromic film inserted into
homogeneous phantoms for different CBCT protocols
[16, 17]. Wen et al. reported cumulative dose levels to the
left femoral head from daily kV CBCT of pelvic sites can
be upwards of 400 cGy. Since 4DCBCT has great potential
in localizing lesions in the thorax, it would be worthwhile
to understand the dose delivered from 4DCBCT in a het-
erogeneous medium and the effect of changing practical
variables in 4D protocols such as gantry speed due to gan-
try speed’s inverse relationship with the number of projec-
tions. This study investigates the effect of gantry speed on
4DCBCT image quality and dose using the On-Board
Imager® (OBI) on the Edge™ radiosurgery system (Varian
Medical System, Palo Alto, CA).
Materials and methods
CBCT parameterization
All images were acquired with 125 kVp x-ray tube setting.
Phantoms were placed at isocenter and were imaged using
a half-fan field of view with a half-bowtie filter and full tra-
jectory slightly greater than 360° acquisition, reflecting a
typical thoracic region protocol in which a larger field of
view is required to prevent truncation of anatomy (see
Table 1). A relatively large focal spot of 1.0 mm was used
to mediate heat loss. The source-to-detector distance was
150 cm. These fixed parameters mirrored a standard thor-
acic CBCT clinical protocol.
The standard Feldkamp-Davis-Kress (FDK) recon-
struction algorithm was used in producing average
Table 1 Technique factors and parameters set with a variable gantry speed. All images were acquired with 125 kVp x-ray tube setting
Gantry speed (°/s) Field of view (cm) Matrix size Pixel size (mm) Slice thickness (mm) Tube voltage (kVp) mAs Projections Δt (min)
1.0 46.5 512 × 512 0.7 2.0 125 5716 5400 6.0
2.0 46.5 512 × 512 0.7 2.0 125 2856 2700 3.0
3.0 46.5 512 × 512 0.7 2.0 125 1903 1800 2.0
4.0 46.5 512 × 512 0.7 2.0 125 1427 1350 1.5
5.0 46.5 512 × 512 0.7 2.0 125 1140 1080 1.2
6.0 46.5 512 × 512 0.7 2.0 125 949 900 1.0
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(CBCT-ave) and 4D reconstructions for all acquisitions
[18]. Projections were sorted retrospectively into bins ac-
cording to their respiratory phase corresponding to a
surrogate signal, as seen in Fig. 1. The surrogate signal
was generated by placing an infrared reflective marker
block on a moving anterior-posterior (AP) platform of a
BrainLAB ExacTrac gating system phantom (BrainLAB,
Heimstetten, Germany) used in tandem with the real-
time position management (RPM) system™ (Varian
Medical Systems, Palo Alto, CA) to track the motion of
the block (see Fig. 2) [19]. An independent computer
controlled the motion of the gating phantom’s platforms.
A well-defined sinusoidal waveform simulated regular
breathing cycles, representing an idealized model for
tumor motion [20–22]. The amplitude of waveform
motion A in cm as a function of phase ϕ is given by:
A ¼ Ao 1− cos 2πϕð Þð Þ2;ϕ∈ 0; 1½  ð1Þ
where A0 represents an amplitude constant in cm. The
RPM system™ tracks the block’s motion with an infrared
camera and assigns projections to appropriate phase bins
used for retrospective reconstruction. The Catphan® 504
phantom was used to evaluate CBCT image quality
(Phantom Laboratory, Salem, NY) by placing it on a
lower moving superior-inferior (SI) platform of the
gating phantom that moved in phase with the infrared
marker block’s platform.
An array of parameters can be varied for CBCT acqui-
sition. The number of projections acquired directly
relates to image quality and imaging dose [23]. The
number of projections N for a given CBCT protocol is
determined by:
N ¼ FΔt ¼ F θ=ωð Þ ð2Þ
where F is the frame rate and Δt is the acquisition time
determined by the angular displacement θ and inversely
by the gantry speed ω. Thus, N varies inversely with ω.
Six protocols were designed by varying gantry speed in
integer steps from 1.0 to 6.0° per second (°/s) at a fixed
frame rate of 15 frames per second (fps) (see Table 1).
Image quality analysis
The following image quality parameters were evaluated:
spatial resolution, low contrast detectability, uniformity,
and difference in Hounsfield unit (HU) sensitivity from
baseline. Image quality metrics were determined for
CBCT-ave for all gantry speeds. Modules for image qual-
ity evaluation are shown in Fig. 3. All image quality mea-
surements were performed using the Eclipse treatment
planning system (Varian Medical Systems, Palo Alto,
CA). Certain image quality parameters specified below
were normalized to the square root of the mAs, as this
represents the anticipated relative noise of the image
and provides a kind of benefit-cost ratio as it pertains to
image quality.
Spatial resolution
A bar pattern module (CTP528) was used to determine
the modulation transfer function (MTF) of every proto-
col to completely characterize the spatial resolution of
the imaging system, as seen in Fig. 3a. The spatial fre-
quency f of the bar patterns are well known. By calculat-
ing the modulation of the bar patterns for various
frequencies [24], a raw MTF can be generated via:
MTFraw fð Þ ¼ HUmax fð Þ−HUmin fð ÞHUmax fð Þ þHUmin fð Þ ð3Þ
These metrics were determined by taking line intensity
profiles across the bar patterns. Gaussian fits were applied
Fig. 1 Idealized surrogate sinusoidal respiratory signal mapped as
relative amplitude as a function of relative phase. The signal is
discretized into a number of phase bins determined by the user
allowing for retrospective 4D reconstruction
Fig. 2 Equipment used in 4D analysis. The Catphan sits on the SI
platform while the block sits on the AP platform. The motion of the
block is recorded and used as the surrogate signal in 4D reconstruction
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to the raw data by maximizing the coefficient of determin-
ation (R2). The final MTF is given by:
MTF fð Þ ¼ exp −f 2=2σ2  ð4Þ
where σ represents the fitting parameter. The maximal
spatial resolution fmax is defined as the frequency at
which the MTF crosses the 10 % level. This was assessed
for every protocol using the Gaussian fits. Variation of
fmax normalized to the square root of mAs was also eval-
uated with respect to mAs.
Low contrast detectability
Quantification of low contrast detectability can be ac-
complished via calculation of the contrast-to-noise
ratio (CNR). A module containing low contrast cylin-
ders (CTP515) was used to determine CNR, as seen
in Fig. 3b. A 1.5 cm in diameter, 1.0 % nominal low
contrast cylinder was defined as the region-of-interest





where xs represents the mean HU in the ROI, xbg repre-
sents the mean HU of the adjacent background, and σbg
represents the standard deviation of the background.
CNR was calculated for ten individual slices and then
averaged producing a single CNR for every protocol.
Variation of CNR normalized to the square root of mAs
was also evaluated with respect to mAs.
Image uniformity
A module composed of homogeneous material
(CTP486) was used to determine image uniformity.
The mean HU values of four ROI 5.0 cm equidistant
Fig. 3 Different slices of the Catphan’s modules used for image quality evaluation. a A bar pattern module of increasing spatial frequency (lp/
cm), used for determining spatial resolution of the protocols. b A low contrast module used in calculating CNR of the various protocols. c A
homogeneous module used in determining uniformity, with four ROI (anterior, posterior, right, and left) equidistant from a centrally located ROI.
d A sensitometry module containing materials of known electron density, used in the calculating HU difference from baseline
Santoso et al. Radiation Oncology  (2016) 11:98 Page 4 of 11
from a centrally located ROI were determined, as seen
in Fig. 3c. The uniformity index (UI) is given by:
UI ¼ HUmax−HUmin ð6Þ
UI was calculated for ten individual slices and then
averaged producing a single UI for every protocol. Vari-
ation of UI normalized to the square root of mAs was
also evaluated with respect to mAs.
HU sensitivity
An imaging system’s ability to accurately characterize
a given material’s electron density (ED) is the essence
of HU sensitivity. This was accomplished via meas-
urement of various cylinders found in the Catphan’s
sensitometry module (CTP404), as seen in Fig. 3d.
The mean HU value of each cylinder was measured
over ten individual slices and then averaged produ-
cing a single mean HU for each cylinder for every
protocol. The difference in mean HU from a baseline
CBCT scan without motion performed at the same
kVp was calculated for every cylinder. Ground truth
of a given material’s HU value is represented by the
baseline scan [25]. This was used to construct a curve
for quantification of HU sensitivity.
4D analysis
Retrospective 4D reconstructions were performed
maintaining the volume-of-interest while varying re-
construction with 4 uncorrelated phases (CBCT-4 ph)
or 10 uncorrelated phases (CBCT-10 ph) as a means
to measure differences in reconstruction quality. Re-
construction time increases linearly with the number
of projections as well as the number of phases (e.g.
approximately 6 and 20 min for CBCT-4 ph and
CBCT-10 ph, respectively with 5400 projections). Ex-
cursion of this study was 3.0 cm in the SI direction
and was calculated by taking the difference in the
maximum and minimum position of the air cylinder
sensitometry insert. Percent differences between ex-
pected excursion and those measured on the
4DCBCT were calculated. To compare excursion be-
tween CBCT-4 ph and CBCT-10 ph, root-mean
square error (RMSE) for excursion was determined
across the different protocols, as projection data for
each protocol was independently acquired. For some
measured excursion E for a given protocol i, the
RMSE for a given 4D reconstruction is given by:
Fig. 4 Ion chamber measurement points within the CIRS IMRT
Thorax phantom
Fig. 5 a Gaussian fit MTF for CBCT-ave for the various protocols. b Maximal spatial resolution normalized to the square root of mAs. As defined
above, the maximal spatial resolution corresponds to the spatial frequency at which the MTF crosses the 10 % contrast level









This was done for both 4D reconstruction techniques.
Reference dosimetry
Following the recommendations of AAPM Task Group
61, an IBA CC13 ionization chamber (IBA Dosimetry
GmbH, Schwarzenbruck, Germany), was used to provide
absolute dose information [26]. The CC13 was calibrated
at an Accredited Dosimetry Calibration Laboratory with
a tungsten target, aluminum filtration beam in the kV
energy range at 100 and 120 kVp, with reported half-
value layers (HVL) of 5.0 and 6.8 mm Al respectively.
The HVL for the 125 kVp spectrum of the OBI was
determined in air using Gammex high purity aluminum
attenuators (Gammex, Middleton, WI). Doses were mea-
sured with an electrometer (Keithley 35040 SN 70422)
by placing the chamber (IBA CC13 SN 7406) at different
coplanar locations within a CIRS IMRT thorax phantom
(Model 002LFC, CIRS Inc, Norfolk, VA) placed upon the
gating phantom and using the same waveform motion
as the Catphan. The plane resided in the central axis
at rest. The CIRS is manufactured using proprietary
materials intended to mimic the attenuation charac-
teristics of water, bone, and lung within 3.0 % for en-
ergies ranging from 50 keV to 25 MeV. The chamber
was placed in regions of the CIRS phantom described
in Fig. 4a (regions 1–3 for water, region 4 for a bone,
and regions 5 and 6 for lung) for every protocol.
These measurements were used to determine dose
rates in the different tissue mimicking materials.
Results
A. Image quality evaluation
Spatial resolution was evaluated for CBCT-ave. The
spatial resolution data are shown in Fig. 5a, exhibiting
linearly decreasing behavior with increasing gantry
speed. Linearly decreasing maximal spatial resolution
with increasing gantry speed is exhibited in Table 2.
Evaluation of maximal spatial resolution normalized to
the square root of mAs a maximum value at 1140 mAs
as seen in Fig. 5b. The inverse square root term in the
fmax normalization dominates as mAs increases.
Low contrast detectability exhibited linear decreases,
with CNR variations from 4.80 to 1.82 as gantry speed
increased from 1.0 to 6.0°/s as seen in Fig. 6a. Evaluation
of CNR normalized to the square root of mAs indicates
small increases up to 1427 mAs as seen in Fig. 6b. The
inverse square root term in the CNR normalization
dominates as mAs increases. Qualitative variation of low
contrast detectability is exhibited in Fig. 7.
Minimal variations between protocols were observed
for image uniformity, as seen in Fig. 8. The difference
between the maximum and minimum UI across all the
Table 2 Maximal spatial resolution (lp/cm) for CBCT-ave at
specified gantry speeds
Gantry speed (°/s)
1.0 2.0 3.0 4.0 5.0 6.0
5.93 5.62 5.14 4.91 4.60 3.82
These spatial frequencies correspond to 10 % contrast of the Gaussian fit
Fig. 6 CNR for CBCT-ave. All values were calculated over ten individual slices and then averaged. Error bars represent standard error. a CNR
exhibits a linear trend as a function of gantry speed. (R2 = 0.988). b CNR normalized to the square root of mAs. Values were calculated over ten
individual slices and then averaged. All error bars represent standard error
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protocols is less than 3.0 HU, as seen in Fig. 8a. Evalu-
ation of UI normalized to the square root of mAs indi-
cates complete dominance of the inverse square root
term as seen in Fig. 8b.
Minimal variations were also observed for HU sensitiv-
ity differences from baseline, as seen in Fig. 9. The largest
variation in mean HU between protocols was observed for
the air cylinder of ED = 0. The difference between the
maximum and minimum average HU for air was 100 HU.
However, all average HU values are within one standard
deviation of each other, in turn making the HU-to-ED
curves even more indistinguishable.
Variations in excursion across 4D reconstruction tech-
niques for all protocols were also minimal. The differ-
ence between the maximum and minimum measured
excursion across all protocols and all reconstruction
techniques was less than 1.0 mm. The RMSE in excur-
sion for CBCT-4 ph and CBCT-10 ph were 0.025 and
0.035 cm, respectively. Percent differences in excursion
are presented in Table 3. No relationship in error to the
known 3.0 cm excursion with the number of projections
was observed.
Imaging dose evaluation
The HVL measured in air was determined to be
5.02 mm Al. Appropriate mass-energy absorption co-
efficients were applied to the tissue-mimicking mate-
rials [26] Resultant dose rates for a given chamber
position are provided in Table 4 below. Comparison
Fig. 7 Low contrast module of the Catphan. Images correspond to gantry speeds varying from 1.0 to 6.0°/s for (a) through (f) respectively
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to other dosimetry studies is provided in the discus-
sion below.
Discussion
CBCT finds great utility in radiation oncology. CBCT
image acquisition prior to delivery of radiation can be reg-
istered to previously acquired CT scans used for treatment
planning and provides images for retrospective dose
accumulation studies. However, standard 3D acquisition
and reconstruction does not allow visualization of mobile
lesions as a function of respiratory phase and is suscep-
tible to motion artifacts such as blurring and distortion.
Moreover, average 3D reconstructions may result in un-
derestimates in excursion due to short periods of time
spent at peak inhalation/exhalation. The use of 4DCBCT
has the potential to mitigate these issues by assigning
Fig. 8 UI for CBCT-ave plotted against a gantry speed and b normalized to mAs. Values were calculated over ten individual slices and then aver-
aged. All error bars represent standard error
Fig. 9 Difference in mean HU from baseline for CBCT-ave. Values were measured over ten individual slices and then averaged
Santoso et al. Radiation Oncology  (2016) 11:98 Page 8 of 11
projections to specific breathing cycle phases. This is feas-
ible due to changes in the diaphragm, causing organ mo-
tion with the diaphragm’s dynamics. This in turn justifies
the use of surrogate signals such as skin surface mapping
or infrared markers, as the position of the surrogate is
variable with respect to time [4, 7].
A major difficulty in 4DCBCT is the limited number
of projections per phase bin. Insufficient projection data
leads to aliasing artifacts. Li and Xing proposed slow
gantry rotation (SGR) and multiple gantry rotation
(MGR) acquisition techniques to increase the number of
projections for a given phase [27]. They showed SGR
produced superior images to MGR for the same mAs
when compared to 3DCBCT counterparts.
Time-averaged 4DCBCT images over the respiratory
cycle are used for patient localization compared
against time-averaged 4DCT images [28]. The image
quality of 4DCBCT images plays an important role in
4D dose accumulation. Anatomical voxels are mapped
from the 4DCBCT at treatment position to a refer-
ence 4DCT. However, the low number of projections
per phase in the 4DCBCT image may result in de-
graded image quality, specifically streaking at high
contrast boundaries and blurring, in turn leading to
unrealistic dose calculations [29].
In this study, contrast-based image quality metrics
were affected by variable gantry speed. Yoganathan et al.
have shown similar results in their analysis of an Elekta
4DCBCT system using a Catphan® 600 [30]. Specifically,
spatial resolution and low contrast detectability de-
creased with increasing gantry speed and a fixed frame
rate. Yoganathan et al. further demonstrated that reduc-
tions in 4DCBCT image quality parameters may result
in underestimates of target volumes when compared to
4DCT contoured volumes used in treatment planning.
Improved metrics with slower acquisition leading to in-
creased projections/mAs is likely due to decreases in
noise. Saturation of these metrics occurs when viewing
the parameters against the number of projections/mAs.
This is related to the imaging system being unable to de-
crease noise levels further. However, normalization of
image quality parameters by the square root of mAs in-
dicates marginal improvements in maximal spatial reso-
lution and low contrast detectability passed a given mAs
and a lack of improvement with respect to uniformity.
The presence of artifacts like streaking, as seen in Fig. 10,
makes evaluation of image quality for 4D volumes diffi-
cult. Cooper et al. have described streaking and star arti-
facts in 4DCBCT being attributed to the presence of
two sampling frequencies – a higher sampling fre-
quency for the projections in a given phase bin and a
lower sampling frequency between phase bins [31]. In
implementing a FDK cone-beam reconstruction with
so few projections per phase, materials with stronger
attenuation characteristics are not balanced out in the
back projection process in turn leading to star and
streaking artifacts [18].
HU sensitivity and excursion did not exhibit note-
worthy differences in CBCT-ave with variable gantry
speed, especially when accounting for error in the
case HU sensitivity. With respect to excursion, across
all the protocols, percent differences were less than
2.0 %. In comparing 4 phase against 10 phase recon-
structions, both RMSE are less than half a millimeter.
This indicates that the 4D reconstructions reproduce
realistic excursion. In this particular study, the 15 fps
acquisition and characteristics of the waveform mo-
tion mitigate issues of latency. Based on the motion
waveform used, acquisition may miss 0.8 mm of mo-
tion between frames on average. For more irregular
breathing patterns, this may not be the case resulting
in errors in the phase sorting process.
Characterization of image quality for given tube current
settings (mAs) for 4DCBCT has been previously per-
formed for systems including the Varian’s Acuity™ simula-
tor and Trilogy™ OBI (Varian Medical Systems, Palo Alto,
CA) [25, 29]. These studies focused primarily on a com-
parison of image quality relative to some reference using
SGR or MGR acquisition techniques. Dose was character-
ized via mAs, as dose is directly proportional to mAs [29].
The CTDI100 metric is not appropriate for dosimetric
evaluation of CBCT scans due to its inability to accom-
modate and record the whole primary beam and scat-
tered radiation [32]. Hence 4DCBCT was evaluated
dosimetrically on an absolute scale. Ion chamber mea-
surements from this study produced dose rates of 3.0 ×
10−03 cGy/mAs at isocenter in a water equivalent
medium. Li et al. reported for the Varian Acuity and
Trilogy systems, a 125 kVp spectrum and tube current
Table 3 Percent differences in excursion for the various
protocols
Gantry speed (°/s)
Volume 1.0 2.0 3.0 4.0 5.0 6.0 RMSE (cm)
CBCT-4 ph −1.34 1.32 −1.34 0.00 −1.68 0.00 0.025
CBCT-10 ph 1.32 1.00 −0.33 0.00 1.00 0.33 0.035
Positive values represent overestimates while negative values represent
underestimates. RMSE across the protocols for a given reconstructed volume is
also provided
Table 4 Dose rates (E-3 cGy/mAs) measured in different tissue-
mimicking materials
Chamber position
1 2 3 4 5 6
2.86 3.03 2.84 5.18 2.49 2.30
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of 80 mA produced dose rates at isocenter of 2.92 × 10
−03 and 2.79 × 10−03 cGy/mAs, respectively [33]. Simi-
larly, Gardner et al. reported isocenter doses using film
in a Wellhofer phantom of (2.72 ± 0.11) × 10−03 cGy/
mAs using TrueBeam OBI and 125 kVp setting. McMil-
lan et al. compared measured dose rates to dose rates
determined using Monte Carlo methods for the OBI kV
imaging system integrated into the Varian Novalis Tx ra-
diosurgery platform (Varian Medical Systems, Palo Alto,
CA) [34]. A dose rate of 2.23 × 10−03 cGy/mAs at iso-
center was calculated for a comparable pelvic CBCT
protocol using a 125 kVp spectrum and a 32 cm
diameter cylindrical CTDI phantom composed of
homogeneous polymethyl methacrylate. Variation in
dose rate in this study from others is attributed to
spectral differences and variations in phantom com-
position and geometry.
While increasing the cumulative mAs increases the
quality of spatial resolution and low contrast detectabil-
ity, the cost of linearly increasing dose and increased 4D
image acquisition and reconstruction time must be
considered. Artifacts such as streaking in 4DCBCT are
largely attributed to the lack of projection data being
used for reconstruction. In this particular study, the in-
cremental improvements in image quality above 2000
projections become unjustified compared to the linear
increases in dose. This corresponds to a gantry speed be-
tween 2 and 3°/s. Clinical use of 4DCBCT systems for
patients relies entirely on intended application.
Conclusions
A quantitative analysis of the Varian OBI’s 4DCBCT cap-
abilities was explored for making clinical decisions. The
effects of gantry speed on 4DCBCT image quality and
dose have been investigated yielding anticipated results.
When using the same technique settings (kVp), variations
in gantry speed change the number of projections used for
reconstruction but maintain the mAs per projection. Un-
surprisingly, contrast-based image quality metrics were
found to decrease linearly with increasing gantry speed
but show marginal improvements when appropriately
normalized to the square root of mAs. The benefit of in-
creased contrast comes at the cost of increased dose,
slower acquisition time, and longer 4D reconstruction
time; the clinical benefits of improved image quality
must be weighed against the costs of decreased effi-
ciency and increased imaging dose. The future of
4DCBCT’s clinical utility relies on further investigation
of image optimization, requiring more than just large-
scale increases in mAs to improve image quality.
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